1-3 of 3
Sung Choe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML

Open Access
Clinical Trials & Observations
Pau Montesinos, Dylan M. Marchione, Christian Récher, Michael Heuser, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Marta Riva, Rodrigo T. Calado, Andre C. Schuh, Su-Peng Yeh, Adriana E Tron, Jianan Hui, Diego A. Gianolio, Sung Choe, Prapti A. Patel, Stéphane De Botton, Courtney D. DiNardo, Hartmut Döhner
Journal: Blood Advances
Blood Adv bloodadvances.2025016399.
https://doi.org/10.1182/bloodadvances.2025016399
Published: 2025
Includes: Supplemental data
Journal Articles

A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML

Free
Clinical Trials & Observations
Emily F. Mason, Olga Pozdnyakova, Mikhail Roshal, Amir T. Fathi, Eytan M. Stein, P. Brent Ferrell, Aaron C. Shaver, Mark Frattini, Hongfang Wang, Lei Hua, Jimmy Mu, Sung Choe, Rengyi Xu, Caroline Almon, Michael Cooper, Richard M. Stone, Robert P. Hasserjian, Michael R. Savona
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2279–2283.
https://doi.org/10.1182/bloodadvances.2020003685
Published: 2021
Includes: Supplemental data
Journal Articles

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1 -mutant relapsed or refractory AML

Free
Clinical Trials & Observations
Sung Choe, Hongfang Wang, Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Justin M. Watts, Daniel A. Pollyea, Amir T. Fathi, Martin S. Tallman, Hagop M. Kantarjian, Richard M. Stone, Lynn Quek, Zenon Konteatis, Lenny Dang, Brandon Nicolay, Parham Nejad, Guowen Liu, Vickie Zhang, Hua Liu, Meredith Goldwasser, Wei Liu, Kevin Marks, Chris Bowden, Scott A. Biller, Eyal C. Attar, Bin Wu
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1894–1905.
https://doi.org/10.1182/bloodadvances.2020001503
Published: 2020
Includes: Supplemental data